US Patent 10954297 Methods of treatment using human anti-IL-23 antibodies
Patent 10954297 was granted and assigned to Janssen Biotech on March, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 20, 2018
Date of Patent
March 23, 2021
Patent Applicant
Patent Application Number
16013141
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10954297 Methods of treatment using human anti-IL-23 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
